Pediatrix Medical Group, Inc. (MD) — Financial statements
Income statement, balance sheet, and cash flow for Pediatrix Medical Group, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 1,914↓4.9% | 2,013↑0.9% | 1,995↑1.1% | 1,972↑3.2% | 1,911 | |
| Cost of Revenue | 1,442↓7.5% | 1,559↓0.9% | 1,573↑4.5% | 1,505↑7.7% | 1,398 | |
| Gross Profit | 472↑3.9% | 454↑7.8% | 422↓9.7% | 467↓9.0% | 513 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| General & Administrative Expenses | 241↑1.0% | 238↑4.8% | 228↓1.7% | 231↓12.1% | 263 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 241↑1.0% | 238↑4.8% | 228↓1.7% | 231↓12.1% | 263 | |
| Other Expenses | 0.00↓100.0% | 285↑52.4% | 187↑196.6% | 63↑34.0% | 47 | |
| Operating Expenses | 241↓54.0% | 523↑26.3% | 414↑40.7% | 294↓5.1% | 310 | |
| Total Costs & Expenses | 1,683↓19.2% | 2,082↑4.7% | 1,987↑10.4% | 1,799↑5.3% | 1,708 | |
| Operating Results | ||||||
| Operating Income | 231↑436.3% | -69↓1038.6% | 7↓95.8% | 173↓14.9% | 203 | |
| Depreciation & Amortization | 22↓32.3% | 32↓10.9% | 36↑1.5% | 36↑10.9% | 32 | |
| EBITDA | 274↑1066.5% | -28↓194.9% | 30↓80.9% | 157↓33.6% | 236 | |
| EBIT | 252↑516.5% | -61↓864.3% | -6↓105.2% | 121↓40.6% | 204 | |
| Interest & Other Income | ||||||
| Net Interest Income | -17↑58.5% | -41↑3.2% | -42↓6.0% | -40↑42.2% | -69 | |
| Interest Income | 19 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 36↓11.7% | 41↓3.2% | 42↑6.0% | 40↓42.2% | 69 | |
| Non-Operating Income | -21↓162.6% | -8↓159.6% | 14↓73.6% | 52↑5102.2% | -1 | |
| Other Income / Expenses | -15↑55.1% | -33↑41.4% | -56↑39.0% | -91↓34.9% | -68 | |
| Income Before Tax | 216↑313.6% | -101↓109.6% | -48↓159.4% | 81↓39.8% | 135 | |
| Income Tax Expense | 51↑2346.7% | -2↓118.9% | 12↓35.9% | 19↓31.0% | 27 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 165↑266.9% | -99↓64.0% | -60↓196.6% | 63↓42.1% | 108 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00↓100.0% | 4↓83.6% | 23 | |
| Net Income | 165↑266.9% | -99↓64.0% | -60↓191.1% | 66↓49.3% | 131 | |
| Bottom-Line Net Income | 165↑266.9% | -99↓64.0% | -60↓191.1% | 66↓49.3% | 131 | |
| EPS (Basic) | 1.94↑263.0% | -1.19↓65.3% | -0.72↓190.0% | 0.80↓47.4% | 1.52 | |
| EPS (Diluted) | 1.94↑263.0% | -1.19↓63.0% | -0.73↓192.4% | 0.79↓48.0% | 1.52 | |
| Weighted Average Shares | 85↑2.3% | 83↓0.8% | 84↑1.3% | 83↓4.0% | 86 | |
| Weighted Average Diluted Shares | 85↑2.3% | 83↑1.4% | 82↓2.3% | 84↓2.7% | 86 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.